Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Circulating Antibodies to IDO/THO Pathway Metabolites in Alzheimer's Disease.

Duleu S, Mangas A, Sevin F, Veyret B, Bessede A, Geffard M.

Int J Alzheimers Dis. 2010 Mar 15;2010. pii: 501541. doi: 10.4061/2010/501541.

2.

The absence of indoleamine 2,3-dioxygenase expression protects against NMDA receptor-mediated excitotoxicity in mouse brain.

Mazarei G, Budac DP, Lu G, Lee H, Möller T, Leavitt BR.

Exp Neurol. 2013 Nov;249:144-8. doi: 10.1016/j.expneurol.2013.08.007. Epub 2013 Aug 30.

PMID:
23994717
3.
4.

Overlapping the Tryptophan Catabolite (TRYCAT) and Melatoninergic Pathways in Alzheimer's Disease.

Maes M, Anderson G.

Curr Pharm Des. 2016;22(8):1074-85. Review.

PMID:
25547097
5.

Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis.

Myint AM, Kim YK.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:304-13. doi: 10.1016/j.pnpbp.2013.08.008. Epub 2013 Oct 31. Review.

PMID:
24184687
6.

Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse.

Saito K, Markey SP, Heyes MP.

Neuroscience. 1992 Nov;51(1):25-39.

PMID:
1465184
8.

Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.

Heyes MP, Saito K, Crowley JS, Davis LE, Demitrack MA, Der M, Dilling LA, Elia J, Kruesi MJ, Lackner A, et al.

Brain. 1992 Oct;115 ( Pt 5):1249-73.

PMID:
1422788
9.

Evaluation of indoleamine 2,3-dioxygenase expression and kynurenine pathway metabolites levels in serum samples of diabetic retinopathy patients.

Munipally PK, Agraharm SG, Valavala VK, Gundae S, Turlapati NR.

Arch Physiol Biochem. 2011 Dec;117(5):254-8. doi: 10.3109/13813455.2011.623705. Epub 2011 Oct 29.

PMID:
22034910
10.

Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.

Schefold JC, Zeden JP, Fotopoulou C, von Haehling S, Pschowski R, Hasper D, Volk HD, Schuett C, Reinke P.

Nephrol Dial Transplant. 2009 Jun;24(6):1901-8. doi: 10.1093/ndt/gfn739. Epub 2009 Jan 20.

PMID:
19155537
11.

The kynurenine pathway in neurodegenerative diseases: mechanistic and therapeutic considerations.

Tan L, Yu JT, Tan L.

J Neurol Sci. 2012 Dec 15;323(1-2):1-8. doi: 10.1016/j.jns.2012.08.005. Epub 2012 Aug 29. Review.

PMID:
22939820
12.
13.

Indoleamine 2,3-dioxygenase-dependent tryptophan metabolites contribute to tolerance induction during allergen immunotherapy in a mouse model.

Taher YA, Piavaux BJ, Gras R, van Esch BC, Hofman GA, Bloksma N, Henricks PA, van Oosterhout AJ.

J Allergy Clin Immunol. 2008 Apr;121(4):983-91.e2. doi: 10.1016/j.jaci.2007.11.021. Epub 2008 Jan 7.

PMID:
18179817
14.
15.

A link between stress and depression: shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression.

Miura H, Ozaki N, Sawada M, Isobe K, Ohta T, Nagatsu T.

Stress. 2008 May;11(3):198-209. doi: 10.1080/10253890701754068. Review.

PMID:
18465467
16.

Alzheimer's and seizures: interleukin-18, indoleamine 2,3-dioxygenase and quinolinic Acid.

Anderson G, Ojala J.

Int J Tryptophan Res. 2010;3:169-73. doi: 10.4137/IJTR.S4603. Epub 2010 Oct 15.

17.

Involvement of the kynurenine pathway in human glioma pathophysiology.

Adams S, Teo C, McDonald KL, Zinger A, Bustamante S, Lim CK, Sundaram G, Braidy N, Brew BJ, Guillemin GJ.

PLoS One. 2014 Nov 21;9(11):e112945. doi: 10.1371/journal.pone.0112945. eCollection 2014.

18.

Poliovirus induces indoleamine-2,3-dioxygenase and quinolinic acid synthesis in macaque brain.

Heyes MP, Saito K, Jacobowitz D, Markey SP, Takikawa O, Vickers JH.

FASEB J. 1992 Aug;6(11):2977-89.

PMID:
1322853
19.

Evaluation of kynurenine pathway metabolism in Toxoplasma gondii-infected mice: implications for schizophrenia.

Notarangelo FM, Wilson EH, Horning KJ, Thomas MA, Harris TH, Fang Q, Hunter CA, Schwarcz R.

Schizophr Res. 2014 Jan;152(1):261-7. doi: 10.1016/j.schres.2013.11.011. Epub 2013 Dec 15.

20.

Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampus.

Guillemin GJ, Brew BJ, Noonan CE, Takikawa O, Cullen KM.

Neuropathol Appl Neurobiol. 2005 Aug;31(4):395-404.

PMID:
16008823

Supplemental Content

Support Center